產(chǎn)品基本信息
產(chǎn)品編號(hào)：C979513
產(chǎn)品名稱：N-(3-(3-Cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)phenyl)-N-ethylacetamide
產(chǎn)品CAS：
規(guī)格含量：50mg
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
C979513
名稱:
N-(3-(3-Cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)phenyl)-N-ethylacetamide
別名:
Zaleplon Oxo Isomeric Impurity;
分子式:
C??H??N?O?
外觀:
白色至白色固體
熔點(diǎn):
276-278°C
分子量:
321.33
儲(chǔ)存:
-20ËšC Freezer, Under Inert Atmosphere
溶解度:
DMSO (Slightly), Methanol (Slightly)
類別:
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
N-(3-(3-Cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)phenyl)-N-ethylacetamide is an impurity of Zaleplon (Z145000), Selective non-benzodiazepine GABAA receptor agonist.
參考文獻(xiàn)
Allen, D., et al.: Eur. J. Clin. Pharmacol., 45, 313 (1993), Beer, B., et al.: J. Clin. Pharmacol., 34, 335 (1994), Rosen, A.S., et al.: Biopharm. Drug Dispos., 20, 171 (1999), Elie, R., et al.: J. Clin. Psychiatry, 60, 536 (1999), Heydorn, W.E., et al.: Expert Opin. Invest. Drugs, 9, 841 (2000)
?您的位置：![N-(3-(3-Cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)phenyl)-N-ethylacetamide](/uploads/allimg/191120/1_11200542014K7.png "N-(3-(3-Cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)phenyl)-N-ethylacetamide")
